Quarterly report pursuant to Section 13 or 15(d)

Reconciliation of IFRS Disclosure to US GAAP Disclosure (Tables)

v3.21.2
Reconciliation of IFRS Disclosure to US GAAP Disclosure (Tables)
9 Months Ended
May 31, 2019
Reconciliation Of Ifrs Disclosure To Us Gaap Disclosure [Abstract]
Schedule of main differences between IFRS and US GAAP
For the three months ended May 31,
2019
May 31,
2018
Net loss and comprehensive loss in accordance with IFRS $ 4,792,890 $ 3,178,839
Share-based compensation (248,912 ) -
Debt issue costs (43,799 ) -
Net loss and comprehensive loss in accordance with US GAAP $ 4,500,179 $ 3,178,839
For the nine months ended May 31,
2019
May 31,
2018
Net loss and comprehensive loss in accordance with IFRS $ 13,747,997 $ 8,557,082
Share-based compensation (746,736 ) -
Debt issue costs 51,894 -
Net loss and comprehensive loss in accordance with US GAAP $ 13,053,155 $ 8,557,082
Schedule of shareholders' equity
May 31,
2019
August 31,
2018
Total shareholders’ equity in accordance with IFRS $ 46,193,400 $ 32,929,400
Components of share capital in accordance with IFRS
Share capital 100,109,913 77,870,606
Shares to be issued 1,068,000 996,401
Share option reserve 14,485,974 12,823,000
Share warrant reserve 6,246,032 3,207,915
121,909,919 94,897,922
Adjustment for:
Share-based compensation (217,862 ) 528,874

Total share capital in accordance with US GAAP

121,692,057 95,426,796

Accumulated deficit in accordance with IFRS

(75,716,519 ) (61,968,522 )
Adjustment for:
Share-based compensation 217,862 -
Debt issue costs (51,894 ) (528,874 )
Accumulated deficit in accordance with US GAAP (75,550,551 ) (62,497,396 )
Shareholders equity in accordance with US GAAP $ 46,141,506 $ 32,929,400